glp 1 agonist australia GLP-1 RA and GIP + GLP-1 RA injections current evidence and uses in – Dr. Victor Liew GLP-1 Receptor Agonists in Australia
Description
Conclusion Historically, pharmacological targeting of obesity has been largely unproductive, with interventions that produced safe weight loss reducing body weight by 5% or less
Let's break it down from a clinical perspective
GLP-1 medications cause nausea primarily because they slow gastric emptying, meaning food stays in the stomach longer
Available from: Pirahanchi Y, Toro F, Jialal I
